Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study

Published:2024-01 Issue:1 Volume:9 Page:102200
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Kang D.-W.^ORCID,Park S.-K.^ORCID,Yu Y.L.,Lee Y.^ORCID,Lee D.H.^ORCID,Kang S.^ORCID

Publisher

Elsevier BV

Reference20 articles.

1. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

2. Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial;Jänne;J Clin Oncol,2012

3. Targeted therapies in non-small cell lung cancer-beyond EGFR and ALK;Rothschild;Cancers (Basel),2015

4. Economic impact of next-generation sequencing versus single-gene testing to detect genomic alterations in metastatic non-small-cell lung cancer using a decision analytic model;Pennell;JCO Precis Oncol,2019

5. Whole genome sequencing for lung cancer;Daniels;J Thorac Dis,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing impact on cancer care: applications, challenges, and future directions;Frontiers in Genetics;2024-07-09

2. Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination;International Journal of Molecular Sciences;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP